Evoke Pharma
(NASDAQ:EVOK)
$1.54
0.05[3.36%]
Last update: 2:55PM (Delayed 15-Minutes)
Get Real Time Here
Day Range1.4 - 1.5552 Wk Range0.23 - 10.03Open / Close1.4 / -Float / Outstanding3.3M / 3.3M
Vol / Avg.14.3K / 13.4KMkt Cap5.1MP/E-50d Avg. Price1.8
Div / Yield-Payout Ratio-Total Float3.3MEPS-0.6

Evoke Pharma Stock (NASDAQ:EVOK), Quotes and News Summary

Evoke Pharma Stock (NASDAQ: EVOK) stock price, news, charts, stock research, profile.

Loading...
Day Range1.4 - 1.5552 Wk Range0.23 - 10.03Open / Close1.4 / -Float / Outstanding3.3M / 3.3M
Vol / Avg.14.3K / 13.4KMkt Cap5.1MP/E-50d Avg. Price1.8
Div / Yield-Payout Ratio-Total Float3.3MEPS-0.6
Globe Newswire - Feb 17, 2022, 8:30AM
Seeking Alpha - Sep 20, 2022, 11:35AM
Seeking Alpha - Jun 15, 2022, 12:58PM
InvestorsObserver - Jun 15, 2022, 11:59AM
Seeking Alpha - Jun 15, 2022, 9:23AM
InvestorsObserver - May 24, 2022, 6:53AM
InvestorsObserver - May 23, 2022, 6:43AM
InvestorsObserver - May 5, 2022, 10:10AM
InvestorsObserver - May 3, 2022, 10:48AM
InvestorPlace - Apr 26, 2022, 2:17PM
InvestorsObserver - Apr 8, 2022, 1:31PM
Sector: Health Care.Industry: Pharmaceuticals
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-0.660-0.600 0.0600
REV570.000K832.100K262.100K
Q2 2022Est.ActualSurprise
EPS-0.600-0.710 -0.1100
REV580.000K461.795K-118.205K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Evoke Pharma (EVOK) stock?

A

You can purchase shares of Evoke Pharma (NASDAQ: EVOK) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Evoke Pharma's (EVOK) competitors?

Q

What is the target price for Evoke Pharma (EVOK) stock?

A

The latest price target for Evoke Pharma (NASDAQ: EVOK) was reported by HC Wainwright & Co. on Monday, June 22, 2020. The analyst firm set a price target for 10.00 expecting EVOK to rise to within 12 months (a possible 549.35% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Evoke Pharma (EVOK)?

A

The stock price for Evoke Pharma (NASDAQ: EVOK) is $1.54 last updated Today at November 30, 2022, 7:55 PM UTC.

Q

Does Evoke Pharma (EVOK) pay a dividend?

A

There are no upcoming dividends for Evoke Pharma.

Q

When is Evoke Pharma (NASDAQ:EVOK) reporting earnings?

A

Evoke Pharma’s Q3 earnings are confirmed for Wednesday, November 9, 2022.

Q

Is Evoke Pharma (EVOK) going to split?

A

There is no upcoming split for Evoke Pharma.

Q

What sector and industry does Evoke Pharma (EVOK) operate in?

A

Evoke Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.